SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

4 hedge funds and large institutions have $62.1K invested in Salarius Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$29.2K
2
+$5.07K
3
+$269

Top Sellers

1
-$16.4K
2
-$15K
3
-$13.1K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$7.7K
5
Osaic Holdings
Osaic Holdings
Arizona
-$252
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$54.1K
2
$7.56K
3
$269
4
$126
5
$17
6
$15
7
$2
8
$2
9
–
10
–
11
–
12
–
13
–